HomeERIS • NSE
add
Eris Lifesciences Ltd
Previous close
₹1,384.60
Day range
₹1,367.60 - ₹1,424.00
Year range
₹1,097.20 - ₹1,910.00
Market cap
191.22B INR
Avg Volume
65.62K
P/E ratio
43.66
Dividend yield
-
Primary exchange
NSE
Market news
Financials
Income Statement
Revenue
Net income
| (INR) | Dec 2025info | Y/Y change |
|---|---|---|
Revenue | 8.01B | 10.91% |
Operating expense | 3.66B | -2.61% |
Net income | 997.20M | 19.24% |
Net profit margin | 12.45 | 7.51% |
Earnings per share | 8.26 | 34.47% |
EBITDA | 2.87B | 35.82% |
Effective tax rate | 25.13% | — |
Balance Sheet
Total assets
Total liabilities
| (INR) | Dec 2025info | Y/Y change |
|---|---|---|
Cash and short-term investments | 747.50M | -69.18% |
Total assets | — | — |
Total liabilities | — | — |
Total equity | 35.03B | — |
Shares outstanding | 136.23M | — |
Price to book | 6.10 | — |
Return on assets | — | — |
Return on capital | 8.96% | — |
Cash Flow
Net change in cash
| (INR) | Dec 2025info | Y/Y change |
|---|---|---|
Net income | 997.20M | 19.24% |
Cash from operations | — | — |
Cash from investing | — | — |
Cash from financing | — | — |
Net change in cash | — | — |
Free cash flow | — | — |
About
Founded
2007
Website
Employees
3,354
